PFN1 and metastatic malignant neoplasm in the lymph nodes: The increase in the number of PFN1-expressing CTCS in HNSCC patients with lymph node metastases and the dependence of the number of CAP1-containing CTCs on the histotype of the primary tumor may be associated with the acquisition of functional features of CTCs during the progression of HNSCC.